Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL0PJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,247
Award facts
- Contract value 100% obligated
- $19,247.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,247.40 delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pens on December 9, 2025, with completion targeted for December 10, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis and other immune-mediated inflammatory conditions, making this procurement consistent with the Defense Health Agency's pharmaceutical supply needs for military medical systems. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contract awards with DLA covering a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies. The delivery order falls within AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through its master IDC vehicle, which enables flexible pharmaceutical support to military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FL0PJ?
SPE2DR26FL0PJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FL0PJ worth?
The government has obligated $19,247 on SPE2DR26FL0PJ.
Is contract SPE2DR26FL0PJ an order under another contract?
Yes. SPE2DR26FL0PJ is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL0PJ competed?
The extent of competition for SPE2DR26FL0PJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award